Cannabis
CANNABIS
Amidst a complex and rapidly changing regulatory scheme, McMillan’s cannabis industry lawyers are at the leading edge of industry developments. McMillan’s Cannabis Practice Group is one of the largest groups of its kind in Canada. Our specialized team of lawyers works closely with a wide range of industry participants, including licensed producers and retailers. They also work with innovators, investors, technology and other service providers, to help them succeed in the medical cannabis industry.
Among Canada’s top business law firms, McMillan is leading the way in providing innovative and practical solutions to business clients in the evolving cannabis industry. Experts in facilitating business growth, McMillan represented Aurora Cannabis Inc. in its US $2.5 billion (CAD $3.2 billion) acquisition of MedReleaf Corp, the largest M&A deal in the Cannabis sector to date in all of Canada. We also represented iAnthus Capital Holdings Inc. in its $835 million acquisition of MPX Bioceutical Corporation, the first public company-to-public company acquisition involving US cannabis assets.
Our lawyers are experienced professionals with significant in-depth knowledge of the laws, regulations and business landscape of Canada’s medical cannabis industry. Our cannabis industry lawyers provide clients with valuable legal solutions for financing, accessing public markets, licensing and regulation, employment law and workplace issues, mergers and acquisitions, tax structuring and intellectual property matters, whether you are just entering the market or you are already established in the sector.
We help our clients lead by:
- structuring financing arrangements through private equity, public markets, and venture capital,
- navigating the complex medical marijuana regulatory system, assisting with regulatory approvals,
- advising on mergers, acquisitions and divestitures,
- assisting with labelling, advertising and distribution matters,
- drafting comprehensive employment agreements and workplace policies in compliance with applicable laws,
- advising on tax matters, and
- assisting with patents, trademarks, licensing, outsourcing and strategic alliances
Primary Contacts
View All ContactsNews
Insights (10 Posts)View More
Towards a Shared Understanding: Canada’s New Sustainable Investment Guidelines & Mandated Climate Disclosures
Canada’s New Sustainable Investment Guidelines (Taxonomy) & Mandated Climate Disclosures
Read More
Nov 4, 2024
×
Sanctions Enforcement Rising: Border Seizures and Forfeitures, Administrative Penalties and a New Reporting Obligation for Sanctions Evasion Offences
Changes to Canada’s sanctions regime under Bill C-59 will add reporting requirements for importers/exporters, create AMPs, and grant new CBSA seizure powers.
Read More
Jun 13, 2024
×
Warning For Businesses: Companies Can be Liable for Tort of Bribery Even if They Did Not Intend to Pay or Receive a Bribe
Businesses with a duty to provide impartial advice must take steps to ensure the payments they make or receive are not later interpreted as bribes.
Read More
Apr 12, 2024
×
CIRO Proposes Amendments to Strengthen Short Selling Regulations
On January 11, 2024, CIRO proposed amendments aimed at strengthening short selling regulations in Canada.
Read More
Jan 17, 2024
×
CSA and CIRO Provide Update on Short Selling Regulatory Regime Review
On November 16, 2023, the CSA and CIRO published CSA/CIRO Staff Notice 23-332 Summary of Comments and Responses to CSA/IIROC Staff Notice 23-329.
Read More
Nov 20, 2023
×
Competition Bureau gets into the weeds of the Cannabis Act
The Competition Bureau's submission to support Health Canada's legislative review of the Cannabis Act investigates the competitive dynamics of cannabis industry
Read More
Sep 6, 2023
×
Good Smoke? More Guidance on Good Faith from the Ontario Court of Appeal
A recent decision by the Ontario Court of Appeal provides more guidance on good faith.
Read More
Feb 14, 2022
×
Has COVID-19 Lit the Fuse on Insolvencies in the Canadian Cannabis Industry?
We look at the recent market analysis of the Canadian cannabis industry and challenges in cannabis restructuring.
Read More
Apr 9, 2020
×
CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A
Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions
Read More
Nov 15, 2019
×
24-Hour Rule: Court Confirms Limits of Medically Prescribed Cannabis Use in the Workplace
The Supreme Court of Newfoundland and Labrador (“Supreme Court”) has issued an important decision about the limits of accommodating the use of medically prescribed cannabis by an employee working in a safety-sensitive position.
Read More
Jun 24, 2019
×
Subscribe for updates
Get updates delivered right to your inbox. You can unsubscribe at any time.